Biomedical (original) (raw)
Latest News for: biomedical
Ignite Biomedical and Liquid Biosciences Partner to Discover First-in-Class Drug Targets
Times Argus 09 Jun 2026
No approved drug, clinical-stage asset, or competing research program targets the mechanisms that Liquid's Emerge platform identifies ....
Syntec Optics (Nasdaq: OPTX) Secures $4.6M Critical-Care Biomedical Order
Nasdaq Globe Newswire 09 Jun 2026
OPTX), a leading innovator in defense tech, space tech, and biomedical ...
Statement of Changes in Beneficial Ownership (Form 4) (Lifecore Biomedical Inc)
Public Technologies 08 Jun 2026
2 ... LIFECORE BIOMEDICAL, INC ... Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that owns more than 10% of Lifecore Biomedical, Inc.'s (the "Issuer") outstanding shares of Common Stock ... Lifecore Biomedical Inc.
Annual Report for Fiscal Year Ending 01-31, 2025 (Form 10-K) (Vitaspring Biomedical Co Ltd)
Public Technologies 08 Jun 2026
As used in this annual report, the terms "we," "us," "our," or "the Company," mean VitaSpring Biomedical Co., Ltd., unless otherwise indicated ... Vitaspring Biomedical Co.
Classiq and UC Chile Launch Quantum AI Research for Biomedical Image Analysis Leveraging Integration with ...
The Daily Record - Dunn 05 Jun 2026
Collaboration expands quantum computing in LATAM, supporting quantum machine learning for digital pathology ....
Cleveland's biomedical economy could pay the price for a new proposed rule on federal funding
Cleveland 05 Jun 2026
... biomedical research in the United States, which is a huge part of Cleveland’s economy.
EXPLANATORY NOTE (Form 6-K) (Psyence Biomedical Ltd)
Public Technologies 05 Jun 2026
On May 4, 2026, the board of directors (the "Board") of Psyence Biomedical Ltd. (the "Company") approved a resolution to amend and restate the Psyence Biomedical Ltd ... 10.1 Psyence Biomedical Ltd.
Proxy Results, Management Change/Compensation (Form 8-K) (Lifecore Biomedical Inc)
Public Technologies 05 Jun 2026
On June 4, 2026, Lifecore Biomedical, Inc ... 4. Approval of the Lifecore Biomedical, Inc ... (4)To approve the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan. 1 ... Katrina L ... Paul H ... 4.Stockholders approved the Lifecore Biomedical, Inc ... Lifecore Biomedical Inc.
Visit to companies Students of the Master's Degree in Biomedical Technologies get to know leaders in the sector up close. 2026·06·05 (Mondragon Unibertsitatea)
Public Technologies 05 Jun 2026
Students of the Master's Degree in Biomedical Technologies get to know leaders in the sector up close ... The students of the Master's Degree in Biomedical Technologies at Mondragon Goi Eskola ...
Australia-China network set to advance collaborative biomedical research (The Walter and Eliza Hall Institute of Medical Research)
Public Technologies 03 Jun 2026
) News Australia-China network set to advance collaborative biomedical research ... The WEHI-China Health Research Network brings together leading and emerging researchers to strengthen biomedical research capability in the region.
Paula Gibbons eyes a career in biomedical sciences
Telegram & Gazette - Worcester 03 Jun 2026
looking at biomedical engineering and biomedical sciences, a broad field that includes pacemakers, prosthetics, and other devices, substances or systems that interact directly with the body.
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
Nasdaq Globe Newswire 02 Jun 2026
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer ... .
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
The Daily Record - Dunn 02 Jun 2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB. OTLC) today announces ....
Alpha Genesis Now Offers African Green Monkeys for Biomedical Research
ACCESSWIRE 02 Jun 2026
The addition strengthens Alpha Genesis' ability to support biomedical research programs requiring scientifically valuable, flexible, and cost-effective nonhuman primate models ... "Biomedical research ...
Kemp Proteins Selected by Avivo Biomedical to Support Process Optimization for Universal Blood Technology Program
PR Newswire 02 Jun 2026
That is the future Avivo Biomedical Inc ... Kemp Proteins and Avivo Biomedical ... universal blood technology to critical care settings," said John Coleman of Avivo Biomedical ... About Avivo Biomedical Inc.